nifedipine has been researched along with Abdominal Aortic Aneurysm in 5 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The hemodynamic responses to captopril 25 mg SL (n = 10) and to nifedipine 10 mg SL (n = 10) were studied for 2 hours in patients (mean age 66 years) with arterial hypertension (mean blood pressure, Pa > or = 115 mmHg) the day after abdominal aortic surgery." | 9.07 | [Treatment of arterial hypertension after surgery of the abdominal aorta: comparison of captopril and nifedipine administrated sublingually]. ( Degaute, JP; Leeman, M, 1993) |
| " Using this unique model we investigated effects on AAA formation of the L-type calcium channel blocker nifedipine, in view of the unclear relationship between hypertension and AAA, and unclear mechanisms of aneurysm protective effects of some blood pressure lowering drugs." | 7.81 | Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications. ( Cai, H; Miao, XN; Siu, KL, 2015) |
| "Aortic aneurysms are prevalent and severe vascular diseases with high mortality from unpredicted ruptures, while the only treatment option is surgical correction of large aneurysms with considerable risk." | 5.72 | Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication. ( Cai, H; Huang, K; Wu, Y; Youn, JY; Zhang, Y, 2022) |
| "Treatment with nifedipine resulted in a significant inhibition of the progression of AAA such as aneurismal dilation at 14 and 28 days compared to the control (week 2: control, 2." | 5.35 | Inhibition of experimental abdominal aortic aneurysm progression by nifedipine. ( Izawa, K; Kunugiza, Y; Morishita, R; Ogihara, T; Osako, MK; Tomita, N; Yamasaki, K, 2008) |
| " The hemodynamic responses to captopril 25 mg SL (n = 10) and to nifedipine 10 mg SL (n = 10) were studied for 2 hours in patients (mean age 66 years) with arterial hypertension (mean blood pressure, Pa > or = 115 mmHg) the day after abdominal aortic surgery." | 5.07 | [Treatment of arterial hypertension after surgery of the abdominal aorta: comparison of captopril and nifedipine administrated sublingually]. ( Degaute, JP; Leeman, M, 1993) |
| " Using this unique model we investigated effects on AAA formation of the L-type calcium channel blocker nifedipine, in view of the unclear relationship between hypertension and AAA, and unclear mechanisms of aneurysm protective effects of some blood pressure lowering drugs." | 3.81 | Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications. ( Cai, H; Miao, XN; Siu, KL, 2015) |
| "Aortic aneurysms are prevalent and severe vascular diseases with high mortality from unpredicted ruptures, while the only treatment option is surgical correction of large aneurysms with considerable risk." | 1.72 | Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication. ( Cai, H; Huang, K; Wu, Y; Youn, JY; Zhang, Y, 2022) |
| "Treatment with nifedipine resulted in a significant inhibition of the progression of AAA such as aneurismal dilation at 14 and 28 days compared to the control (week 2: control, 2." | 1.35 | Inhibition of experimental abdominal aortic aneurysm progression by nifedipine. ( Izawa, K; Kunugiza, Y; Morishita, R; Ogihara, T; Osako, MK; Tomita, N; Yamasaki, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, K | 3 |
| Wu, Y | 3 |
| Zhang, Y | 3 |
| Youn, JY | 3 |
| Cai, H | 4 |
| Miao, XN | 1 |
| Siu, KL | 1 |
| Tomita, N | 1 |
| Yamasaki, K | 1 |
| Izawa, K | 1 |
| Kunugiza, Y | 1 |
| Osako, MK | 1 |
| Ogihara, T | 1 |
| Morishita, R | 1 |
| Leeman, M | 1 |
| Degaute, JP | 1 |
| Antonucci, F | 1 |
| Calo, L | 1 |
| Rizzolo, M | 1 |
| Cantaro, S | 1 |
| Bertolissi, M | 1 |
| Travaglini, M | 1 |
| Geatti, O | 1 |
| Borsatti, A | 1 |
| D'Angelo, A | 1 |
2 trials available for nifedipine and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
[Treatment of arterial hypertension after surgery of the abdominal aorta: comparison of captopril and nifedipine administrated sublingually].
Topics: Administration, Sublingual; Aged; Aortic Aneurysm, Abdominal; Captopril; Drug Evaluation; Humans; Hy | 1993 |
Nifedipine can preserve renal function in patients undergoing aortic surgery with infrarenal crossclamping.
Topics: Aged; Aortic Aneurysm, Abdominal; Calcium Channel Blockers; Dopamine; Endothelins; Glomerular Filtra | 1996 |
3 other studies available for nifedipine and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Disease Models, Animal; Folic | 2022 |
Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Disease Models, Animal; Folic | 2022 |
Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Disease Models, Animal; Folic | 2022 |
Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Disease Models, Animal; Folic | 2022 |
Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Aneurysm, Abdominal; Calcium Channel | 2015 |
Inhibition of experimental abdominal aortic aneurysm progression by nifedipine.
Topics: Animals; Aortic Aneurysm, Abdominal; Blood Pressure; Blotting, Western; Calcium Channel Blockers; Ce | 2008 |